AIZ vs PRAX · P/E 15, rev $3.45B vs $7.38B cap
Assurant Inc (AIZ) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the AIZ and PRAX stock pages for the full models.
Not investment advice.